| DeepBrain AI Launches Interactive AI Video Agents for Enterprise |
Globe Newswire |
03/24 |
04:50 |
| Smithfield Foods Reports Record Fiscal 2025 Results |
Globe Newswire |
03/24 |
04:30 |
| Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant |
Globe Newswire |
03/24 |
04:30 |
| Hesai Group Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results |
Globe Newswire |
03/24 |
04:30 |
| Netflix’s Chief Marketing Officer, Marian Lee, Takes Center Stage at Licensing Expo 2026 for an Opening Keynote on the Netflix Effect and Fandom |
Globe Newswire |
03/24 |
04:00 |
| Kandi Technologies Unveils Brand Upgrade to Highlight Intelligent Transformation and Diversified Growth Strategy |
Globe Newswire |
03/24 |
04:00 |
| Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini |
Globe Newswire |
03/24 |
03:26 |
| Progress on share buyback programme |
Globe Newswire |
03/24 |
03:00 |
| Press release: Availability of the Q1 2026 aide-mémoire |
Globe Newswire |
03/24 |
02:30 |
| Technip Energies convenes its 2026 Annual General Meeting |
Globe Newswire |
03/24 |
02:30 |
| SBM Offshore awarded FEED contracts for the Longtail project in Guyana |
Globe Newswire |
03/24 |
02:30 |
| CGTN: How Xiongan is evolving into a model for high-quality urban growth |
Globe Newswire |
03/24 |
02:21 |
| Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid |
Globe Newswire |
03/24 |
02:00 |
| Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older |
Globe Newswire |
03/24 |
02:00 |
| Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP) |
Globe Newswire |
03/24 |
02:00 |
| Phonak AI-Powered Hearing Aids Recognized with 2026 Artificial Intelligence Excellence Awards |
Globe Newswire |
03/24 |
01:05 |
| anynines advances Klutch to power a9s Hub for Kubernetes data service orchestration across on-premises and AWS environments |
Globe Newswire |
03/24 |
01:00 |
| BYND DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Beyond Meat, Inc. Investors to Secure Counsel Before Important March 24 Deadline in Securities Class Action - BYND |
Globe Newswire |
03/23 |
23:58 |
| ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action – CORT |
Globe Newswire |
03/23 |
23:51 |
| ROSEN, NATIONAL TRIAL LAWYERS, Encourages Concorde International Group Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIGL |
Globe Newswire |
03/23 |
23:39 |
| TCPC DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BlackRock TCP Capital Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TCPC |
Globe Newswire |
03/23 |
23:35 |
| Progressive Prices $1.5 Billion of Senior Notes |
Globe Newswire |
03/23 |
22:06 |
| LOBO Announces Pricing of $2 Million Public Offering |
Globe Newswire |
03/23 |
22:00 |
| Boralex Responds to Recent Statements in the Media |
Globe Newswire |
03/23 |
21:13 |
| VITL Investor News: If You Have Suffered Losses in Vital Farms, Inc. (NASDAQ: VITL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights |
Globe Newswire |
03/23 |
20:00 |
